» Articles » PMID: 37165131

In Reply: Sex-specific Outcomes in COVID-19: Missing Pieces of the Puzzle

References
1.
Magoon R, Jose J . Comment on: "Outcomes of critically ill older adults with COVID-19: a multicentre retrospective cohort study". Can J Anaesth. 2023; 70(12):2020-2021. DOI: 10.1007/s12630-023-02598-w. View

2.
Wolff G, Wernly B, Flaatten H, Fjolner J, Bruno R, Artigas A . Sex-specific treatment characteristics and 30-day mortality outcomes of critically ill COVID-19 patients over 70 years of age-results from the prospective COVIP study. Can J Anaesth. 2022; 69(11):1390-1398. PMC: 9363137. DOI: 10.1007/s12630-022-02304-2. View

3.
Jung C, Flaatten H, Fjolner J, Bruno R, Wernly B, Artigas A . The impact of frailty on survival in elderly intensive care patients with COVID-19: the COVIP study. Crit Care. 2021; 25(1):149. PMC: 8054503. DOI: 10.1186/s13054-021-03551-3. View

4.
Wilcox T, Smilowitz N, Seda B, Xia Y, Hochman J, Berger J . Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19. Am J Cardiol. 2022; 170:112-117. PMC: 8908016. DOI: 10.1016/j.amjcard.2022.01.024. View

5.
Spyropoulos A, Goldin M, Giannis D, Diab W, Wang J, Khanijo S . Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial. JAMA Intern Med. 2021; 181(12):1612-1620. PMC: 8498934. DOI: 10.1001/jamainternmed.2021.6203. View